Table 2.
First generation gene expression signatures
| Gene signature | MammaPrint | OncotypeDX | MapQuantDX | Breast cancer ındex | PAM 50 assay |
| Starting material | FF or stabilized RNA, FFPE | FFPE | FFPE, FF | FFPE | FFPE |
| Analytical platform | Microarray, RT-PCR | qRT-PCR | Microarray, qRT-PCR | qRT-PCR | nCounter |
| Number of genes | 70 | 21 | 97/9 | 7 | 50 |
| Indications | Stage I/II, 5 cm, ER (+), Node (-)/[1-3 Node (+)] | ER(+), Node (-) | ER (+), G2 | ER (+) | All, Node (-) untreated |
| Application | Clinical outcome | Clinical outcome, benefit from chemotherapy | Molecular grading prediction of response to TMX | Clinical outcome, prediction of response to TMX | Subtype definition, risk of relapse without treatment |
| FDA approved | Yes | No | No | No | No |
| ASCO and NCCN recommendation | No | Yes | No | No | No |
FF: Fresh frozen; FFPE: Formalin fixed paraffin embedded; G: Grade; TMX: Tamoxifen.